MedPath

Objective Measurement With TCM Pattern for AIDDES

Recruiting
Conditions
Sjögren's Syndrome
Systemic Lupus Erythematosus
Dry Eye Syndrome
Registration Number
NCT04747288
Lead Sponsor
Taipei Veterans General Hospital, Taiwan
Brief Summary

To explore the association with TCM pattern and TCM tongue diagnosis for Autoimmune disease and Dry eye syndrome.

Detailed Description

Objective: To explore the association with TCM pattern and TCM tongue diagnosis for Autoimmune disease and Dry eye syndrome.

Method:

This study wants to include the 1000 Autoimmune disease (AID) subjects as 800 Sjögren's syndrome (SJS) and 200 Systemic lupus erythematosus (SLE) for comparing with the 500 Dry eye syndrome (DES) subjects. AID and DES subjects will be enrolled to evaluate at V1 Baseline and follow-up for 6 times evaluation with one month interval during one year. And the non-AID-non-DES healthy control subjects will be also included in our study for comparison with the dry eye syndrome and healthy control. This study want to use objective measurement and questionnaires as TCM pattern, OSDI, ESSPRI, SF-36, Schirmer's test, TCM heart rate variability, and TCM tongue diagnosis to differentiate AID, DES and healthy control.

Expected Results:

1. To evaluate the difference among TCM pattern, OSDI, ESSPRI, SF-36, Schirmer's test, TCM heart rate variability, and TCM tongue diagnosis to differentiate between AID and DES.

2. To evaluate the difference among TCM pattern and TCM tongue diagnosis among the AID groups, DES group, and healthy control.

Keyword: Autoimmune disease, Sjögren's syndrome, Systemic lupus erythematosus, Dry eye syndrome, TCM pattern, TCM tongue diagnosis.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1800
Inclusion Criteria
  1. aged between 20 and 75 years
  2. fulfilled the 2002 American-European Consensus Criteria for SS (AECG)
Exclusion Criteria

NA

Systemic lupus erythematosus

  • Inclusion Criteria:

    1. aged between 20 and 75 years
    2. fulfilled the 1982 and 1997 ACR revised Systemic lupus erythematosus criteria
  • Exclusion Criteria: NA

Dry eye syndrome

  • Inclusion Criteria:

    1. aged between 20 and 75 years
    2. Schirmer's test less than 10 mm/5 min
  • Exclusion Criteria: NA

non AIDDES Healthy Controls

  • Inclusion Criteria:

    1. aged between 20 and 75 years
    2. without any Chronic disease
  • Exclusion Criteria: any Sjögren's syndrome, Systemic lupus erythematosus, or Dry eye syndrome.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
OSDI(Ocular Surface Disease Index)One year

OSDI is a tool to rate the severity of dry eye disease among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), and Dry eye syndrome (DES).

ESSPRI(EULAR Sjögren's Syndrome Patient Reported Index)One year

ESSPRI is a tool for evaluating the symptoms of SJS among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), and Dry eye syndrome (DES).

TCM tongue diagnosisOne year

TCM tongue diagnosis is a tool for detecting tongue expression among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Dry eye syndrome (DES), and healthy control.

Heart rate variability (HRV)One year

Heart rate variability (HRV) is a tool for detecting ratio between High-frequency (HF) activity and low-frequency (LF) activity among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE),and Dry eye syndrome (DES).

SF-36(36-Item Short Form Survey )One year

SF-36 is a tool for evaluating Health-Related Quality of Life among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), and Dry eye syndrome (DES).

Schirmer's testOne year

Schirmer's test is a tool for evaluating aqueous tear production among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), and Dry eye syndrome (DES).

TCM patternOne year

TCM pattern is a tool for detecting the constitution among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Dry eye syndrome (DES), and healthy control.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ching-Mao Chang

🇨🇳

Taipei, Taiwan

Ching-Mao Chang
🇨🇳Taipei, Taiwan
Chang Ching-Mao, M.D., Ph.D.
Contact
88628757453 Ext. 333
magicbjp@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.